Activation of human somatostatin receptor 2 promotes apoptosis through a mechanism that is independent from induction of p53

Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
Rosa TeijeiroVictor M Arce

Abstract

The ability of both somatostatin (SS) and its stable analogues to inhibit cell growth depends on the stimulation of specific membrane receptors (SSTR1-5), which belong to the G protein-coupled receptor family. Accumulating evidence suggests that the SSTR2 plays a major role in mediating cell cycle arrest, and it is also clear that SHP-1, a cytoplasmic phosphotyrosine phosphatase (PTP), is an essential component of the SSTR2-mediated cytostatic effect. In contrast, the possibility that SSTR2 activation may also lead to increased apoptosis is still beyond debate, despite SHP-1 activation is also able to promote cell death in several cell types. In the present work we have investigated the ability of SSTR2 to induce apoptosis in HL-60 cells. We have found that HL-60 cells uniquely express the SSTR2 subtype, and that stimulation of SSTR2 with the SS analogue SMS 201-995 results in an increased cell death. In all, these findings demonstrate that activation of SSTR2 promotes apoptosis in HL-60 cells. Moreover, in contrast with the proapoptotic mechanism previously reported for SSTR3, cell death induced by activation of SSTR2 is independent from accumulation of p53.

Citations

Jan 13, 2005·Naunyn-Schmiedeberg's Archives of Pharmacology·Niki MastrodimouKyriaki Thermos
Dec 20, 2005·The Journal of Membrane Biology·F LangS M Huber
Apr 14, 2004·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·C BousquetC Susini
Apr 14, 2004·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·D FeroneL J Hofland
Nov 26, 2002·Journal of Neuroimmunology·D LattuadaO Marelli
Nov 6, 2009·Journal of Experimental & Clinical Cancer Research : CR·Maximilian Schöniger-HekeleChristian Müller
Jan 11, 2014·Trends in Endocrinology and Metabolism : TEM·Mounira ChalabiCorinne Bousquet
May 19, 2009·Expert Review of Anticancer Therapy·Kjell Oberg
Aug 15, 2009·Expert Opinion on Investigational Drugs·Pavlos MsaouelMichael Koutsilieris
Jul 23, 2013·Frontiers in Neuroendocrinology·Marily Theodoropoulou, Günter K Stalla
Apr 17, 2004·The Journal of Investigative Dermatology·Shinichi InoueToshiyasu Shimomura
May 10, 2015·Pharmacology & Therapeutics·Uma RaiSimon A Young
Mar 25, 2008·Molecular and Cellular Endocrinology·Stéphane PyronnetChristiane Susini
Mar 30, 2007·Regulatory Peptides·Danica M Petrović-DjergovićMićić V Mileva
May 22, 2004·Annals of the New York Academy of Sciences·Hicham LahlouChristiane Susini
Feb 7, 2012·European Journal of Clinical Investigation·Ioulia EvangelouMichael Koutsilieris
Jul 16, 2010·Journal of Cellular and Molecular Medicine·Mehtap CakirAshley Grossman
Jul 13, 2004·Journal of Hepatology·Michael BläkerAndreas De Weerth
Nov 23, 2006·Journal of Neuroimmunology·D LattuadaO Marelli
Sep 27, 2005·Best Practice & Research. Clinical Gastroenterology·Julie Guillermet-GuibertChristiane Susini
May 1, 2015·Upsala Journal of Medical Sciences·Eva LudvigsenMats Stridsberg
Jun 29, 2016·Expert Opinion on Pharmacotherapy·Filippo MaffezzoniAndrea Giustina
Feb 18, 2004·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Eva LudvigsenStellan Sandler
Dec 5, 2003·Nature Reviews. Drug Discovery·Gisbert WeckbeckerChristian Bruns
Dec 3, 2010·Endocrine Reviews·Annamaria ColaoRosario Pivonello
Aug 27, 2005·Acta Oncologica·Marie-Louise Fjällskog, Eva Tiensuu Janson
Jan 17, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Thierry VoisinMarc Laburthe
Nov 24, 2004·Applied Immunohistochemistry & Molecular Morphology : AIMM·Guida Maria Portela-GomesRaimund Weitgasser
Jan 1, 2011·Journal of lung cancer·J Clay CallisonPierre P Massion
Jun 5, 2018·Pathology Oncology Research : POR·Attila ZalatnaiEszter Perjési
Mar 31, 2004·World Journal of Gastroenterology : WJG·Jing-Hua WangMeng-Biao Yuan
Mar 31, 2004·World Journal of Gastroenterology : WJG·Qin PanQin-Fang Xu
Feb 5, 2021·Journal of Clinical Medicine·Maria Celeste CantoneGiovanni Vitale

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis